Dr. An-Chi Tien received his Ph.D. from Baylor College of Medicine in Houston, Texas, before completing a postdoctoral fellowship in the Rowitch Laboratory at the University of California at San Francisco. Dr. Tien is a Principal Investigator at the Ivy Brain Tumor Center. As the leader of our Pharmacodynamic Core, Dr. Tien has been involved in numerous early-phase clinical trials and has innovated in the space of Phase 0 clinical trials design. His Ph.D. and subsequent scientific training is focused on overlapping mechanisms governing CNS development as well as its deregulation in glioblastoma formation. His current academic and scientific interests focus on cancer-related signaling pathways regulating gliomagenesis and glioma progression.